Other
Settlement expense
Edwards Lifesciences Settlement expense decreased by 82.2% to $37.1M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 240.4%, from $10.9M to $37.1M. Over 4 years (FY 2021 to FY 2025), Settlement expense shows an upward trend with a 99.4% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2014
Last reportedQ1 2026May 6, 2026
Metric ID:
other_litigation_settlement_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.4M | $4.7M | $7.1M | $7.1M | $6.1M | -$2.4M | $5M | $43.5M | $147.9M | $2.2M | $9.9M | $8.9M | $8.1M | $10.8M | $12.6M | $10.9M | $15.5M | $90.4M | $208.6M | $37.1M |
| QoQ Change | — | +95.8% | +51.1% | +0.0% | -14.1% | -139.3% | +308.3% | +770.0% | +240.0% | -98.5% | +350.0% | -10.1% | -9.0% | +33.3% | +16.7% | -13.5% | +42.2% | +483.2% | +130.8% | -82.2% |
| YoY Change | — | — | — | — | +154.2% | -151.1% | -29.6% | +512.7% | >999% | +191.7% | +98.0% | -79.5% | -94.5% | +390.9% | +27.3% | +22.5% | +91.4% | +737.0% | >999% | +240.4% |
Range-$2.4M – $208.6M
CAGR+78.0%
Avg YoY Growth+374.5%
Median YoY Growth+126.1%
Frequently Asked Questions
- What is Edwards Lifesciences's settlement expense?
- Edwards Lifesciences (EW) reported settlement expense of $37.1M in Q1 2026.
- How has Edwards Lifesciences's settlement expense changed year-over-year?
- Edwards Lifesciences's settlement expense increased by 240.4% year-over-year, from $10.9M to $37.1M.
- What is the long-term trend for Edwards Lifesciences's settlement expense?
- Over 4 years (2021 to 2025), Edwards Lifesciences's settlement expense has grown at a 99.4% compound annual growth rate (CAGR), from $20.6M to $325.4M.